Alle verbonden artikelen

Tumour-infiltrating lymphocytes in non-invasive breast cancer: A systematic review and meta-analysis.

Auteurs : Caparica R, Bruzzone M, Agostinetto E, Franzoi MA, Ceppi M, Radosevic-Robin N, Penault-Llorca F, Willard-Gallo K, Loi S, Salgado R, de Azambuja E
Jaar : 2021
Journal : Breast
Volume : 59
Pagina's : 183-192

Copy Number Aberration Analysis to Predict Response to Neoadjuvant Anti-HER2 Therapy: Results from the NeoALTTO Phase III Clinical Trial.

Auteurs : Venet D, Rediti M, Maetens M, Fumagalli D, Brown DN, Majjaj S, Salgado R, Pusztai L, Harbeck N, El-Abed S, Wang Y, Saura C, Gomez H, Semiglazov VF, de Azambuja E, Huober J, Nuciforo P, Di Cosimo S, Piccart-Gebhart M, Loi S, Rothé F, Sotiriou C
Jaar : 2021
Journal : Clin Cancer Res
Volume : 27
Pagina's : 5607-5618

B cells and cancer.

Auteurs : Engelhard V, Conejo-Garcia JR, Ahmed R, Nelson BH, Willard-Gallo K, Bruno TC, Fridman WH
Jaar : 2021
Journal : Cancer Cell
Volume : 39
Pagina's : 1293-1296

Fluorescent Multiplex Immunohistochemistry Coupled With Other State-Of-The-Art Techniques to Systematically Characterize the Tumor Immune Microenvironment.

Auteurs : Boisson A, Noël G, Saiselet M, Rodrigues-Vitória J, Thomas N, Fontsa ML, Sofronii D, Naveaux C, Duvillier H, Craciun L, Larsimont D, Awada A, Detours V, Willard-Gallo K, Garaud S
Jaar : 2021
Journal : Front Mol Biosci
Volume : 8
Pagina's : 673042

A review of immune checkpoint blockade in breast cancer.

Auteurs : Pellegrino B, Tommasi C, Cursio OE, Musolino A, Migliori E, De Silva P, Senevirathne TH, Schena M, Scartozzi M, Farci D, Willard-Gallo K, Solinas C
Jaar : 2021
Journal : Semin Oncol
Volume : 48
Pagina's : 208-225

A Pathologist-Annotated Dataset for Validating Artificial Intelligence: A Project Description and Pilot Study.

Auteurs : Dudgeon SN, Wen S, Hanna MG, Gupta R, Amgad M, Sheth M, Marble H, Huang R, Herrmann MD, Szu CH, Tong D, Werness B, Szu E, Larsimont D, Madabhushi A, Hytopoulos E, Chen W, Singh R, Hart SN, Sharma A, Saltz J, Salgado R, Gallas BD
Jaar : 2021
Journal : J Pathol Inform
Volume : 12
Pagina's : 45

Downregulation of the FTO m⁶A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitors.

Auteurs : Jeschke J, Collignon E, Al Wardi C, Krayem M, Bizet M, Jia Y, Garaud S, Wimana Z, Calonne E, Hassabi B, Morandini R, Deplus R, Putmans P, Dube G, Singh NK, Koch A, Shostak K, Rizzotto L, Ross RL, Desmedt C, Bareche Y, Rothé F, Lehmann-Che J, Duterque-Coquillaud M, Leroy X, Menschaert G, Teixeira L, Guo M, Limbach PA, Close P, Chariot A, Leucci E, Ghanem G, Yuan BF, Willard-Gallo K, Sotiriou C, Marine JC, Fuks F
Jaar : 2021
Journal : Nat Cancer
Volume : 2
Pagina's : 611-628

The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group.

Auteurs : El Bairi K, Haynes HR, Blackley E, Fineberg S, Shear J, Turner S, de Freitas JR, Sur D, Amendola LC, Gharib M, Kallala A, Arun I, Azmoudeh-Ardalan F, Fujimoto L, Sua LF, Liu SW, Lien HC, Kirtani P, Balancin M, El Attar H, Guleria P, Yang W, Shash E, Chen IC, Bautista V, Do Prado Moura JF, Rapoport BL, Castaneda C, Spengler E, Acosta-Haab G, Frahm I, Sanchez J, Castillo M, Bouchmaa N, Md Zin RR, Shui R, Onyuma T, Husain Z, Willard-Gallo K, Coosemans A, Perez EA, Provenzano E, Ericsson PG, Richardet E, Mehrotra R, Sarancone S, Ehinger A, Rimm DL, Bartlett JMS, Viale G, Denkert C, Hida AI, Sotiriou C, Loibl S, Hewitt SM, Badve S, Symmans WF, Kim RS, Pruneri G, Goel S, Francis PA, Inurrigarro G, Yamaguchi R, Garcia-Rivello H, Horlings H, Afqir S, Salgado R, Adams S, Kok M, Dieci MV, Michiels S, Demaria S, Loi S
Jaar : 2021
Journal : NPJ Breast Cancer
Volume : 7
Pagina's : 150

Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity.

Auteurs : Noël G, Fontsa ML, Garaud S, De Silva P, de Wind A, Van den Eynden GG, Salgado R, Boisson A, Locy H, Thomas N, Solinas C, Migliori E, Naveaux C, Duvillier H, Lucas S, Craciun L, Thielemans K, Larsimont D, Willard-Gallo K
Jaar : 2021
Journal : J Clin Invest
Volume : 131

Persistent anti-tumor response in cancer patients experiencing pneumonitis related to immune checkpoint blockade.

Auteurs : Belcaid L, Garaud S, Kerger J, Spyridon S, Aspeslagh S
Jaar : 2021
Journal : Acta Clin Belg
Volume : 76
Pagina's : 144-148

RNA Based Approaches to Profile Oncogenic Pathways From Low Quantity Samples to Drive Precision Oncology Strategies.

Auteurs : van de Stolpe A, Verhaegh W, Blay JY, Ma CX, Pauwels P, Pegram M, Prenen H, De Ruysscher D, Saba NF, Slovin SF, Willard-Gallo K, Husain H
Jaar : 2021
Journal : Front Genet
Volume : 11
Pagina's : 598118

Targeting CTLA-4 in cancer: Is it the ideal companion for PD-1 blockade immunotherapy combinations?

Auteurs : De Silva P, Aiello M, Gu-Trantien C, Migliori E, Willard-Gallo K, Solinas C
Jaar : 2021
Journal : Int J Cancer
Volume : 149
Pagina's : 31-41

Luminal Breast Cancer: Risk of Recurrence and Tumor-Associated Immune Suppression.

Auteurs : Pellegrino B, Hlavata Z, Migali C, De Silva P, Aiello M, Willard-Gallo K, Musolino A, Solinas C
Jaar : 2021
Journal : Mol Diagn Ther
Volume : 25
Pagina's : 409-424

Murlentamab, a Low Fucosylated Anti-Müllerian Hormone Type II Receptor (AMHRII) Antibody, Exhibits Anti-Tumor Activity through Tumor-Associated Macrophage Reprogrammation and T Cell Activation.

Auteurs : Prat M, Salon M, Allain T, Dubreuil O, Noël G, Preisser L, Jean B, Cassard L, Lemée F, Tabah-Fish I, Pipy B, Jeannin P, Prost JF, Barret JM, Coste A
Jaar : 2021
Journal : Cancers (Basel)
Volume : 13

Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer.

Auteurs : Zahavi T, Salmon-Divon M, Salgado R, Elkin M, Hermano E, Rubinstein AM, Francis PA, Di Leo A, Viale G, de Azambuja E, Ameye L, Sotiriou C, Salmon A, Kravchenko-Balasha N, Sonnenblick A
Jaar : 2021
Journal : NPJ Breast Cancer
Volume : 7
Pagina's : 67

Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group.

Auteurs : Amgad M, Stovgaard ES, Balslev E, Thagaard J, Chen W, Dudgeon S, Sharma A, Kerner JK, Denkert C, Yuan Y, AbdulJabbar K, Wienert S, Savas P, Voorwerk L, Beck AH, Madabhushi A, Hartman J, Sebastian MM, Horlings HM, Hudecek J, Ciompi F, Moore DA, Singh R, Roblin E, Balancin ML, Mathieu MC, Lennerz JK, Kirtani P, Chen IC, Braybrooke JP, Pruneri G, Demaria S, Adams S, Schnitt SJ, Lakhani SR, Rojo F, Comerma L, Badve SS, Khojasteh M, Symmans WF, Sotiriou C, Gonzalez-Ericsson P, Pogue-Geile KL, Kim RS, Rimm DL, Viale G, Hewitt SM, Bartlett JMS, Penault-Llorca F, Goel S, Lien HC, Loibl S, Kos Z, Loi S, Hanna MG, Michiels S, Kok M, Nielsen TO, Lazar AJ, Bago-Horvath Z, Kooreman LFS, van der Laak JAWM, Saltz J, Gallas BD, Kurkure U, Barnes M, Salgado R, Cooper LAD
Jaar : 2020
Journal : NPJ Breast Cancer
Volume : 6
Pagina's : 16

Radiomics and radi-…omics" in cancer immunotherapy: a guide for clinicians."

Auteurs : Porcu M, Solinas C, Mannelli L, Micheletti G, Lambertini M, Willard-Gallo K, Neri E, Flanders AE, Saba L
Jaar : 2020
Journal : Crit Rev Oncol Hematol
Volume : 154
Pagina's : 103068

Programmed Cell Death-Ligand 2: A Neglected But Important Target in the Immune Response to Cancer?

Auteurs : Solinas C, Aiello M, Rozali E, Lambertini M, Willard-Gallo K, Migliori E
Jaar : 2020
Journal : Transl Oncol
Volume : 13
Pagina's : 100811

The rationale behind targeting the ICOS-ICOS ligand costimulatory pathway in cancer immunotherapy.

Auteurs : Solinas C, Gu-Trantien C, Willard-Gallo K
Jaar : 2020
Journal : ESMO Open
Volume : 5

Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials.

Auteurs : Hudecek J, Voorwerk L, van Seijen M, Nederlof I, de Maaker M, van den Berg J, van de Vijver KK, Sikorska K, Adams S, Demaria S, Viale G, Nielsen TO, Badve SS, Michiels S, Symmans WF, Sotiriou C, Rimm DL, Hewitt SM, Denkert C, Loibl S, Loi S, Bartlett JMS, Pruneri G, Dillon DA, Cheang MCU, Tutt A, Hall JA, Kos Z, Salgado R, Kok M, Horlings HM, + collaborators (among others :, Larsimont D
Jaar : 2020
Journal : NPJ Breast Cancer
Volume : 6
Pagina's : 15